Baxter Alerted FDA To Problem Before Receiving Warning Letter, Firm Says
This article was originally published in The Gray Sheet
Executive Summary
Baxter says it has already corrected a key problem cited in an FDA warning letter released Oct. 20, and that it was the company itself that first identified and voluntarily reported the issue to FDA